Log in

OTCMKTS:APPBApplied Biosciences Stock Price, Forecast & News

$0.20
0.00 (0.00 %)
(As of 07/27/2020)
Add
Compare
Today's Range
$0.20
Now: $0.20
$0.20
50-Day Range
$0.15
MA: $0.23
$0.35
52-Week Range
$0.05
Now: $0.20
$1.00
VolumeN/A
Average Volume8,154 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Applied Biosciences Corp. focuses on various areas of the medical, bioceutical, and pet health industry. The company focuses on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries. It offers medical and consumer products, including creams, balms, tinctures, concentrates, and edibles under the Applied BioSciences brand. The company also sells clothing, apparel, and other branded products. Applied Biosciences Corp. was founded in 2016 and is based in Beverly Hills, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:APPB
CUSIPN/A
CIKN/A
Phone310-356-7374

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees15
Next Earnings DateN/A
OptionableNot Optionable
$0.20
0.00 (0.00 %)
(As of 07/27/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive APPB News and Ratings via Email

Sign-up to receive the latest news and ratings for APPB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied Biosciences (OTCMKTS:APPB) Frequently Asked Questions

How has Applied Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Applied Biosciences' stock was trading at $0.4350 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APPB shares have decreased by 55.2% and is now trading at $0.1950.
View which stocks have been most impacted by Coronavirus
.

Has Applied Biosciences been receiving favorable news coverage?

Headlines about APPB stock have been trending negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Applied Biosciences earned a news sentiment score of -2.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Applied Biosciences
.

Who are some of Applied Biosciences' key competitors?

What other stocks do shareholders of Applied Biosciences own?

Who are Applied Biosciences' key executives?

Applied Biosciences' management team includes the following people:
  • Mr. Christopher Michael Bridges, Pres & Director (Age 40)
  • Dr. Raymond W. Urbanski, CEO & Member of Advisory Board (Age 60)
  • Mr. David Fiene, Controller (Age 48)
  • Mr. John James Southard, Sec. & Treasurer (Age 41)

What is Applied Biosciences' stock symbol?

Applied Biosciences trades on the OTCMKTS under the ticker symbol "APPB."

How do I buy shares of Applied Biosciences?

Shares of APPB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied Biosciences' stock price today?

One share of APPB stock can currently be purchased for approximately $0.20.

What is Applied Biosciences' official website?

The official website for Applied Biosciences is www.appliedbiocorp.com.

How can I contact Applied Biosciences?

The company can be reached via phone at 310-356-7374.

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.